734.350000
741.900000
1
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
Please wait...
| Financial Year | Full AR | Chairman's Speech |
Director's Report |
Management Discussion |
Corporate Governance |
Auditor's Report |
Notes to Accounts |
|---|---|---|---|---|---|---|---|
| 2021 |
|
||||||
| 2020 |
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
| Time Period | Alembic Pharmaceuticals | S&P BSE Healthcare | S&P BSE Mid Cap |
|---|---|---|---|
| YTD | -7.67 | -17.46 | -12.65 |
| 1 month | 0.91 | -3.75 | -3.14 |
| 3 months | -2.78 | -10.67 | -7.95 |
| 1 Year | -26.08 | -14.72 | -3.66 |
| 3 Years | 13.32 | 18.83 | 13.78 |
| 5 Years | 7.95 | 9.09 | 8.50 |
| 10 Years | 29.79 | 12.34 | 13.67 |
| Year | Alembic Pharmaceuticals | S&P BSE Mid Cap | S&P BSE Healthcare |
|---|---|---|---|
| 2021 | -23.09 | 39.18 | 20.87 |
| 2020 | 87.72 | 19.87 | 61.45 |
| 2019 | -2.65 | -3.05 | -3.55 |
| 2018 | 12.90 | -13.31 | -5.89 |
| 2017 | -10.84 | 48.13 | 0.49 |
| 2016 | -13.48 | 7.97 | -12.88 |
| 2015 | 56.35 | 7.43 | 15.06 |
Mid caps that are thriving on growth & value
We try to generate 20 per cent returns
Update On India Branded Business
Business Update On F.Y. 2021-22
now and be among the first to discover Stock Ideas